Chengdu Olymvax Biopharmaceuticals Inc. (688319.SS)
CNY 11.25
(2.18%)
CNY 11.25
(2.18%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 44 Million | -24.54 Million | 39.96 Million | 21.08 Million | -41.76 Million | -16.69 Million |
| Net Income | 11.44 Million | 26.57 Million | 107.96 Million | 36.13 Million | -31.04 Million | -19 Million |
| Depreciation & Amortization | 30.8 Million | 25.3 Million | 23.03 Million | 17.62 Million | 14.94 Million | 9.24 Million |
| Deferred income taxes | -4.36 Million | -2.18 Million | -4.8 Million | - | 33.1 Thousand | -27 Thousand |
| Stock-based compensation | 8.37 Million | 2.96 Million | - | - | - | - |
| Change in working capital | -14 Million | -97.6 Million | -98.05 Million | -41.31 Million | -31.12 Million | -10.12 Million |
| Other non-cash items | 10.33 Million | 20.4 Million | 7.01 Million | 8.64 Million | 5.45 Million | 3.19 Million |
| Investing Cash Flow | -78.84 Million | -56.99 Million | -255.93 Million | -48.62 Million | -28.2 Million | 2.07 Million |
| Investments in PPE | -169.88 Million | -200.69 Million | -69.7 Million | -38.84 Million | -29.2 Million | -18.11 Million |
| Acquisitions | 16.68 Million | 17.64 Million | 8200.00 | 38.85 Million | 29.2 Million | - |
| Investment purchases | -60 Million | -325 Million | -1.04 Billion | -78 Million | -175 Million | - |
| Sales/Maturities of investments | 151.04 Million | 468.7 Million | 853.76 Million | 68.21 Million | 175.99 Million | 20.18 Million |
| Other Investing Activities | 91.04 Million | -17.64 Million | 0.96 | -38.84 Million | -29.2 Million | -0.13 |
| Financing Cash Flow | 129.26 Million | 103.38 Million | 368.79 Million | 18.37 Million | 154.12 Million | 19.59 Million |
| Debt repayment | -108.18 Million | -40 Million | -25 Million | -5 Million | -25 Million | -20 Million |
| Dividends payments | -5.98 Million | -4.25 Million | -1.02 Million | -754.69 Thousand | -494.02 Thousand | -400.26 Thousand |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 27.06 Million | 147.63 Million | 394.82 Million | 24.12 Million | 179.62 Million | 19.99 Million |
| Accounts receivables | 984.86 Thousand | -151.92 Million | -147.16 Million | -78.61 Million | -77.01 Million | -11.49 Million |
| Accounts payables | -12.29 Million | 64.46 Million | 81.19 Million | 51.64 Million | 58.2 Million | 8.27 Million |
| Inventory | 1.67 Million | -7.96 Million | -27.28 Million | -14.34 Million | -12.34 Million | -6.87 Million |
| Other working capital | -16.66 Million | -2.18 Million | -4.8 Million | -0.01 | 33.18 Thousand | -3.24 Million |
| Cash at beginning of period | 261.11 Million | 239.26 Million | 86.44 Million | 95.61 Million | 11.46 Million | 6.48 Million |
| Cash at end of period | 355.53 Million | 261.11 Million | 239.26 Million | 86.44 Million | 95.61 Million | 11.46 Million |
| Capital Expenditure | -169.88 Million | -200.69 Million | -69.7 Million | -38.84 Million | -29.2 Million | -18.11 Million |
| Effect of forex changes on cash | - | -0.69 | - | 1.07 | - | 1.04 |
| Net cash flow / Change in cash | 94.42 Million | 21.84 Million | 152.82 Million | -9.16 Million | 84.15 Million | 4.98 Million |
| Free Cash Flow | -125.88 Million | -225.24 Million | -29.74 Million | -17.75 Million | -70.96 Million | -34.8 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 31.97 Million | -1.95 Million | -25.99 Million | -12.72 Million | 11.44 Million | 1.73 Million |
| Depreciation & Amortization | - | 8.81 Million | 8.81 Million | 30.8 Million | 30.8 Million | -14.63 Million |
| Deferred income taxes | - | - | - | - | -4.36 Million | - |
| Stock-based compensation | - | - | - | 8.37 Million | 8.37 Million | - |
| Change in working capital | - | - | - | 2.66 Million | -14 Million | 9.54 Million |
| Other non-cash items | -35.54 Million | 18.48 Million | -39.39 Million | 33.69 Million | 10.33 Million | 14.26 Million |
| Investing Cash Flow | -55.69 Million | -101.36 Million | -67.3 Million | -102.23 Million | -78.84 Million | 42.66 Million |
| Investments in PPE | -38.69 Million | -70.36 Million | -38.32 Million | -102.26 Million | -169.88 Million | -12.7 Million |
| Acquisitions | - | - | - | 16.68 Million | 16.68 Million | - |
| Investment purchases | -100 Million | -75 Million | -39 Million | -5 Million | -60 Million | - |
| Sales/Maturities of investments | 83 Million | 44 Million | 10.01 Million | 5.02 Million | 151.04 Million | 55.37 Million |
| Other Investing Activities | - | - | -28.98 Million | 23.99 Thousand | 91.04 Million | -0.83 |
| Financing Cash Flow | 15.98 Million | 36.06 Million | 63.95 Million | 59.6 Million | 129.26 Million | 25.76 Million |
| Debt repayment | -22.38 Million | -55.15 Million | -66.65 Million | -55.55 Million | -108.18 Million | -35.02 Million |
| Dividends payments | - | -19.09 Million | -2.7 Million | -2.3 Million | -5.98 Million | -1.68 Million |
| Common Stock Repurchased | - | - | - | -10.33 Million | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -6.39 Million | -19.09 Million | -2.7 Million | 6.34 Million | 27.06 Million | 62.47 Million |
| Accounts receivables | - | - | - | 984.86 Thousand | 984.86 Thousand | 2.99 Million |
| Accounts payables | - | - | - | - | -12.29 Million | - |
| Inventory | - | - | - | 1.67 Million | 1.67 Million | 6.54 Million |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 235.74 Million | 293.32 Million | 355.53 Million | 343.73 Million | 261.11 Million | 264.76 Million |
| Cash at end of period | 192.46 Million | 235.74 Million | 286.78 Million | 355.53 Million | 355.53 Million | 343.73 Million |
| Capital Expenditure | -38.69 Million | -70.36 Million | -38.32 Million | -102.26 Million | -169.88 Million | -12.7 Million |
| Effect of forex changes on cash | - | - | - | - | - | -372.9 Thousand |
| Net cash flow / Change in cash | -43.28 Million | -57.57 Million | -68.75 Million | 11.8 Million | 94.42 Million | 78.97 Million |
| Free Cash Flow | -42.26 Million | -62.64 Million | -103.72 Million | -47.82 Million | -125.88 Million | -1.79 Million |
AQUEF
MHC-U
601518
AEXFF
JETMF
UCBJY